Sutro Biopharma Inc (STRO)
NASDAQ:STRO

Sutro Biopharma (STRO) Financial Statements

523 Followers

Sutro Biopharma Financial Overview

Sutro Biopharma's market cap is currently ―. The company's EPS TTM is $-1.889; its P/E ratio is -2.20; Sutro Biopharma is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.79. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 13.01M$ 113.72M$ 16.92M$ 10.41M$ 12.67M
Gross Profit$ 13.01M$ 113.72M$ 16.92M$ 10.41M$ 12.67M
EBIT$ -48.82M$ 55.60M$ -47.15M$ -37.97M$ -50.16M
EBITDA$ -47.05M$ 57.34M-$ -38.08M$ -50.33M
Net Income Common Stockholders$ -58.21M$ 31.07M$ -40.57M$ -38.52M$ -50.05M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 313.22M$ 375.62M$ 355.15M$ 391.64M$ 276.49M
Total Assets$ 403.40M$ 470.74M$ 431.73M$ 464.90M$ 358.02M
Total Debt$ 28.07M$ 33.63M$ 38.17M$ 42.66M$ 46.56M
Net Debt$ -285.15M$ -341.98M$ -316.98M$ -348.99M$ -229.93M
Total Liabilities$ 305.38M$ 321.09M$ 319.39M$ 310.18M$ 172.60M
Stockholders Equity$ 98.05M$ 149.65M$ 112.35M$ 154.70M$ 185.41M
Cash Flow-
Free Cash Flow$ -64.74M$ 12.63M-$ -31.20M$ -60.99M
Operating Cash Flow$ -64.74M$ 14.07M$ -33.50M$ -31.20M$ -60.99M
Investing Cash Flow$ 64.11M$ -23.51M$ -114.02M$ 66.16M$ 67.45M
Financing Cash Flow$ -3.43M$ -3.13M$ -5.74M$ 137.66M$ 8.76M
Currency in USD

Sutro Biopharma Earnings and Revenue History

Sutro Biopharma Debt to Assets

Sutro Biopharma Cash Flow

Sutro Biopharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis